| Authors: |
Stamatouli AM; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT., Quandt Z; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA., Perdigoto AL; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT., Clark PL; Department of Immunobiology, Yale University, New Haven, CT., Kluger H; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT., Weiss SA; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT., Gettinger S; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT., Sznol M; Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT., Young A; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA., Rushakoff R; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA., Lee J; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA., Bluestone JA; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Anderson M; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA., Herold KC; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, CT kevan.herold@yale.edu.; Department of Immunobiology, Yale University, New Haven, CT. |
